Search
for
Sort by
Research 30 of 1000+
- JAK Family Expression and Therapeutic Implications in Primary Cicatricial Alopecias
- FDA approves Pfizer's JAK inhibitor for adolescents with alopecia areata hair loss
- Ritlecitinib in Alopecia Areata: A 24‐Week Real‐World Experience Contrasting JAK Inhibitor‐Naïve and JAK Inhibitor‐Experienced Patients
- Hair growth–promoting effects of Enz_MoriL on human dermal papilla cells through modulation of the Wnt/β-Catenin and JAK-STAT signaling pathways
- A clinical case of familial alopecia areata in combination with immune pathology
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- Innovative Therapeutic Strategies in TYK2-Targeted Treatments: From Cancer to Autoimmune Disorders
- Identification of potential key genes and pathways associated with the Pashmina fiber initiation using RNA-Seq and integrated bioinformatics analysis
- Expanding the Scope of PROTACs: Opportunities and Challenges in Topical Delivery
- Multiomics Analysis of the Response to Ritlecitinib in Alopecia Areata Subtypes and Correlation With Efficacy
- Alopecia areata and ritlecitinib: Unravelling response trajectories
- Poster Presentations at the 28th Joint Meeting of the International Society of Dermatopathology, March 5–6, 2025, Orlando, Florida, USA
- Modern dermatology brings treatment even for alopecia areata
- Case Report: Repigmentation and complete hair regrowth in an 11-year-old preadolescent with alopecia totalis treated with a JAK inhibitor
- Follicular Vitiligo: A Rare and Under Recognized Variant
- Pattern hair loss distribution: a novel presentation for alopecia areata
- Hair today, gone tomorrow
- Pathophysiology of Alopecia Areata in the Pediatric Patient
- Forging the Future: 2018 Alopecia Areata Research Summit Summary Report
- Alopecia Universalis with Frequently Relapsing Nephrotic Syndrome of Infantile Onset: A Rare Presentation
- Alopecia Areata: Current Review
- Childhood Alopecia Areata: An Overview of Treatment and Recent Patents
- Free Papers Medical and Surgical: Hair and Nails
- Alopecia Areata
- 455 Beyond Immunity: TEC and JAK3 Kinase Activation in Melanocytes Drives Inflammation in Vitiligo
- JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician
- Janus kinase (JAK) inhibitors for the treatment of skin and hair disorders: a review of literature
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- 331 An open label clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- The Role of JAK Inhibitors in Atopic Dermatitis, Alopecia Areata, and Vitiligo: A Review article